Previous Article | Next Article 
Infection and Immunity, April 2004, p. 2052-2056, Vol. 72, No. 4
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.4.2052-2056.2004
Flea-Borne Transmission Model To Evaluate Vaccine Efficacy against Naturally Acquired Bubonic Plague
Clayton O. Jarrett,1 Florent Sebbane,1 Jeffrey J. Adamovicz,2 Gerard P. Andrews,2 and B. Joseph Hinnebusch1*
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840,1
Division of Bacteriology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 217022
Received 26 November 2003/
Returned for modification 2 January 2004/
Accepted 14 January 2004
A flea-to-mouse transmission model was developed for use in testing new candidate vaccines for the ability to protect against flea-borne plague. The model was used to evaluate a recombinant fusion protein vaccine consisting of the Yersinia pestis F1 and V antigens. After one to three challenges with Y. pestis-infected fleas, 14 of 15 unvaccinated control mice developed plague, with an average septicemia level of 9.2 x 108 Y. pestis CFU/ml. None of 15 vaccinated mice developed the disease after similar challenges, and serological testing indicated that transmitted bacteria were eliminated by the immune system before extensive replication and systemic infection could occur. The transmission and development of disease in control mice correlated with the number of bites by blocked fleas but not with the total number of fleabites. The model provides a means to directly assess the efficacy of new vaccines to prevent naturally acquired bubonic plague and to study events at the vector-host interface that lead to dissemination and disease.
* Corresponding author. Mailing address: Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 S. 4th St., Hamilton, MT 59840. Phone: (406) 363-9260. Fax: (406) 363-9394. E-mail:
jhinnebusch{at}niaid.nih.gov.
Editor: J. B. Bliska
Infection and Immunity, April 2004, p. 2052-2056, Vol. 72, No. 4
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.4.2052-2056.2004
This article has been cited by other articles:
-
Cornelius, C. A., Quenee, L. E., Elli, D., Ciletti, N. A., Schneewind, O.
(2009). Yersinia pestis IS1541 Transposition Provides for Escape from Plague Immunity. Infect. Immun.
77: 1807-1816
[Abstract]
[Full Text]
-
Sebbane, F., Jarrett, C., Gardner, D., Long, D., Hinnebusch, B. J.
(2009). The Yersinia pestis caf1M1A1 Fimbrial Capsule Operon Promotes Transmission by Flea Bite in a Mouse Model of Bubonic Plague. Infect. Immun.
77: 1222-1229
[Abstract]
[Full Text]
-
Anisimov, A. P., Bakhteeva, I. V., Panfertsev, E. A., Svetoch, T. E., Kravchenko, T. B., Platonov, M. E., Titareva, G. M., Kombarova, T. I., Ivanov, S. A., Rakin, A. V., Amoako, K. K., Dentovskaya, S. V.
(2009). The subcutaneous inoculation of pH 6 antigen mutants of Yersinia pestis does not affect virulence and immune response in mice. J Med Microbiol
58: 26-36
[Abstract]
[Full Text]
-
Bubeck, S. S., Cantwell, A. M., Dube, P. H.
(2007). Delayed Inflammatory Response to Primary Pneumonic Plague Occurs in Both Outbred and Inbred Mice. Infect. Immun.
75: 697-705
[Abstract]
[Full Text]
-
Glynn, A., Roy, C. J., Powell, B. S., Adamovicz, J. J., Freytag, L. C., Clements, J. D.
(2005). Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens. Infect. Immun.
73: 5256-5261
[Abstract]
[Full Text]